Neumora Therapeutics Inc.... (NMRA)
NASDAQ: NMRA
· Real-Time Price · USD
0.78
-0.01 (-1.64%)
At close: Jun 18, 2025, 3:59 PM
0.77
-0.58%
After-hours: Jun 18, 2025, 07:33 PM EDT
-1.64% (1D)
Bid | 0.75 |
Market Cap | 125.45M |
Revenue (ttm) | n/a |
Net Income (ttm) | -258.06M |
EPS (ttm) | -1.61 |
PE Ratio (ttm) | -0.48 |
Forward PE | -0.85 |
Analyst | Hold |
Ask | 0.82 |
Volume | 377,232 |
Avg. Volume (20D) | 977,473 |
Open | 0.79 |
Previous Close | 0.79 |
Day's Range | 0.77 - 0.82 |
52-Week Range | 0.61 - 17.19 |
Beta | 2.74 |
About NMRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NMRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NMRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-1.89%
NMRA stock has given up its prior gain. Neumora Th...
Unlock content with
Pro Subscription
1 month ago
-1.89%
Neumora Therapeutics shares are trading higher. The company reported Q1 financial results.

1 month ago · seekingalpha.com
Neumora Therapeutics, Inc. (NMRA) Q1 2025 Earnings Call TranscriptNeumora Therapeutics, Inc. (NASDAQ:NMRA ) Q1 2025 Results Conference Call May 12, 2025 4:30 PM ET Company Participants Helen Rubinstein - Vice President of Investor Relations & Communications Paul Ber...